Tele-cancer: Reducing time-to-treatment for patients with lung cancer

I. Arosi (Wigan, United Kingdom), K. Heyes (Wigan, United Kingdom), V. Sibanda (Wigan, United Kingdom), R. Sundar (Wigan, United Kingdom)

Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Session: Lung cancer: risk factors, supportive measures and quality improvement
Session type: Thematic Poster
Number: 2835
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Arosi (Wigan, United Kingdom), K. Heyes (Wigan, United Kingdom), V. Sibanda (Wigan, United Kingdom), R. Sundar (Wigan, United Kingdom). Tele-cancer: Reducing time-to-treatment for patients with lung cancer. 2835

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Causes of hospitalization in patients with lung cancer
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC)
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019


Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005

The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Lung cancer in patients with COPD: Incidence and predicting factors
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


First hospitalization in lung cancer patients – is timing important?
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Factors affecting the duration from diagnosis to treatment in patients with lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

VATS in lung cancer treatment: for which patients?
Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases
Year: 2014



Clinical factors of long-term survival in patients with advanced lung cancer
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

Clinical impact of steps-count during hospitalization after surgery in lung cancer patients
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients?
Source: Eur Respir J 2002; 19: 464-468
Year: 2002



Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018

Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Analysis of the patients with primary lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 562s
Year: 2007

Survival of elderly small-cell lung cancer patients
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010

Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


The survival in elderly patients after resection of lung cancer
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008